Mark D. McKee

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore, Ed Gane, Jörg Täubel et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

Helena Harlin, Yuru Meng, Amy Peterson et al. · Cancer Research · 2009 · 1.1K citations · Full text

Medicine, Immunology, Oncology +17

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

Sibylle Loibl, Joyce O’Shaughnessy, Michael Untch et al. · The Lancet Oncology · 2018 · 771 citations

Medicine, Oncology, Pharmacology +14

Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

Călin Cainap, Shukui Qin, Wen‐Tsung Huang et al. · Journal of Clinical Oncology · 2014 · 635 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema

Hilary Longhurst, Karen Lindsay, Remy S. Petersen et al. · New England Journal of Medicine · 2024 · 166 citations

Life Sciences, Genetics, Molecular Genetics +14